Expert Pharmaceutical Serialization & Traceability Solutions
Protecting your supply chain from costly delays, delivering life-saving medicines to the patients who need them.
Experts in DSCSA Requirements, Serialization Strategy, & Exceptions Handling
Our experts help to educate and guide you through navigating the intricacies of global track and trace compliance standards, and provide long-term support for the day-to-day operations of your compliance systems.
Whether you're preparing for the 2025 DSCSA compliance deadlines, managing serialization data, handling suspect or illegitimate product investigations, or improving standard operating procedures, we have the experience to keep your business compliant and your pharmaceutical supply chain moving efficiently.
98%
Scorecard Average
for Criterion Clients
5/16/25 - 6/2/25
“Working with Criterion is almost like having a full-time, in-house DSCSA SME team on staff.”
Michael Frank
Commercial Operations Manager
Elite Pharmaceuticals
Our Services
Consulting Services
We tailor solutions to your unique needs and technological landscapes, ensuring you meet global pharmaceutical serialization and DSCSA requirements. Our experience and expertise in this space is unmatched.
SECURE Support
Let our SECURE Support Specialists help protect your pharmaceutical supply chain from costly disruptions. We offer team augmentation and experienced industry leadership to help manage your complex compliance systems.
Content from the Consultants
Read about the current state of the pharmaceutical industry, major events, and the latest in DSCSA compliance.
DSCSA 2025 Deadlines Are Approaching — Is Your Team Ready?
With the May 27 deadline for manufacturers behind us, and
final 2025 DSCSA enforcement deadlines rapidly approaching
– August 27 for wholesale distributors, and November 27 for dispensers –
the industry is bracing for impact.
Most of the attention has gone to EPCIS data exchanges, digital credentials, and system readiness. But I want to shift focus for a moment. Let’s talk about process. Because while data matters and systems matter, what’s going to make or break a successful audit (or a drug shortage) is whether your people know what to do when something goes wrong. And right now, based on what the FDA and several state boards of pharmacy have found in recent audits, that “what to do” isn’t always clear.
Read more.
